These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

414 related items for PubMed ID: 28895028

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Drug-induced long QT in adult psychiatric inpatients: the 5-year cross-sectional ECG Screening Outcome in Psychiatry study.
    Girardin FR, Gex-Fabry M, Berney P, Shah D, Gaspoz JM, Dayer P.
    Am J Psychiatry; 2013 Dec; 170(12):1468-76. PubMed ID: 24306340
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Prescribing Practices of QT Interval Prolonging Drugs in Critically Ill Older Adults in South India.
    Moolambally SR, Malik A, Boloor A A.
    Kathmandu Univ Med J (KUMJ); 2023 Dec; 21(83):298-303. PubMed ID: 39206650
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Risperidone, QTc interval prolongation, and torsade de pointes: a systematic review of case reports.
    Vieweg WV, Hasnain M, Hancox JC, Baranchuk A, Digby GC, Kogut C, Crouse EL, Koneru JN, Deshmukh A, Pandurangi AK.
    Psychopharmacology (Berl); 2013 Aug; 228(4):515-24. PubMed ID: 23812796
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation?
    Mayet S, Gossop M, Lintzeris N, Markides V, Strang J.
    Drug Alcohol Rev; 2011 Jul; 30(4):388-96. PubMed ID: 21355918
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Assessment of drug-induced torsade de pointes risk for hospitalized high-risk patients receiving QT-prolonging agents.
    Jardin CG, Putney D, Michaud S.
    Ann Pharmacother; 2014 Feb; 48(2):196-202. PubMed ID: 24301687
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. QT interval prolongation and the risk of torsades de pointes: essentials for clinicians.
    Trinkley KE, Page RL, Lien H, Yamanouye K, Tisdale JE.
    Curr Med Res Opin; 2013 Dec; 29(12):1719-26. PubMed ID: 24020938
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Incidences, risk factors, and clinical correlates of severe QT prolongation after the use of quetiapine or haloperidol.
    Wang CL, Wu VC, Lee CH, Wu CL, Chen HM, Huang YT, Chang SH.
    Heart Rhythm; 2024 Mar; 21(3):321-328. PubMed ID: 38231170
    [Abstract] [Full Text] [Related]

  • 40. Determinants of torsades de pointes in older patients with drug-associated long QT syndrome: a case-control study.
    Goutelle S, Sidolle E, Ducher M, Caron J, Timour Q, Nony P, Gouraud A.
    Drugs Aging; 2014 Aug; 31(8):601-9. PubMed ID: 24923384
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.